🇺🇸 FDA
Pipeline program

Treprostinil

07-11-087-01

Approved small_molecule completed

Quick answer

Treprostinil for Pulmonary Arterial Hypertension is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 3 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Pulmonary Arterial Hypertension
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials